Journal
GENES
Volume 12, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/genes12101469
Keywords
hypertrophic cardiomyopathy; MYBPC3; MYH7; genotype-phenotype; speckle tracking; myocardial deformation analysis; longitudinal strain; echocardiography
Categories
Funding
- Medical University of Graz
- Pfizer Inc. (New York, NY, USA)
Ask authors/readers for more resources
Our study suggests that myocardial deformation analysis may not be helpful in concluding on the underlying HCM genotype, and vice versa.
Accumulating evidence suggests that individuals with sarcomeric hypertrophic cardiomyopathy (HCM) carrying MYH7 mutations may have a worse prognosis than MYBPC3 mutation carriers. Myocardial deformation analysis is superior to standard echocardiography in detecting subtle myocardial dysfunction and scar formation, but studies evaluating the association with HCM genotype are scarce. We therefore aimed to compare myocardial strain parameters between MYBPC3 and MYH7 mutation carriers with proven HCM. Participants of the prospective Graz HCM Registry carrying at least one causative mutation in MYBPC3 (n = 39) or MYH7 (n = 18) were enrolled. MYBPC3 mutation carriers were older, predominantly male and more often treated with an implantable cardioverter-defibrillator (39% vs. 0%; p = 0.002). Using analyses of covariance, there were no significant differences between MYBPC3 and MYH7 mutation carriers with regard to left ventricular global longitudinal strain (estimated marginal means & PLUSMN; standard deviation: -16.9 & PLUSMN; 0.6% vs. -17.3 & PLUSMN; 0.9%; p = 0.807) and right ventricular 6-segments endocardial strain (-24.3 & PLUSMN; 1.0% vs. 26.3 & PLUSMN; 1.5%; p = 0.285). Our study suggests, that myocardial deformation analysis may not be helpful in concluding on the underlying HCM genotype, and vice versa.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available